Recent Updates on Microinjector based Suprachoroidal Gene Therapy: Potentials & Challenges

Time: 10:00 am
day: Post Conference Day


  • SCS microinector based suprachoroidal gene delivery enables minimally invasive
    office-based treatment for choroiretinal diseases
  • Nanoparticle based non-viral gene delivery via SC injection has potential to be a
    repeatable office-based gene therapy